Article Details
Retrieved on: 2024-02-07 21:24:07
Tags for this article:
Click the tags to see associated articles and topics
Summary
Aytu BioPharma Inc., a pharmaceutical company in the biopharma industry, plans to report its Q2 fiscal 2024 results and hosts a call on February 14, 2024. Its products cover ADHD management with amphetamine ODTs, allergy medication, and fluoride vitamin supplements, overseen by the FDA.
Article found on: www.pharmiweb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here